Pharmacological/JJ
control/NN
of/IN
antigen/NN
responsiveness/NN
in/IN
genetically/RB
modified/VBN
T/NN
lymphocytes/NNS
./.

A/DT
chimeric/JJ
TCR/NN
gene/NN
,/,
comprising/VBG
an/DT
anti-hapten/JJ
single-chain/JJ
Ab/NN
variable/JJ
fragment/NN
fused/VBN
to/TO
the/DT
transmembrane/JJ
and/CC
cytoplasmic/JJ
regions/NNS
of/IN
the/DT
human/JJ
TCR/NN
zeta-chain/NN
,/,
was/VBD
used/VBN
to/TO
determine/VB
whether/IN
the/DT
tetracycline-regulatable/JJ
system/NN
could/MD
be/VB
used/VBN
to/TO
regulate/VB
gene/NN
expression/NN
in/IN
T/NN
cells/NNS
./.
=====
Jurkat/NN
T/NN
cells/NNS
were/VBD
stably/RB
transfected/VBN
with/IN
a/DT
single/JJ
vector/NN
encoding/VBG
the/DT
tetracycline/NN
trans-activator/JJ
protein/NN
,/,
controlled/VBN
by/IN
a/DT
constitutive/JJ
promoter/NN
,/,
and/CC
the/DT
chimeric/JJ
TCR/NN
,/,
under/IN
the/DT
control/NN
of/IN
a/DT
trans-activator/JJ
protein-responsive/JJ
promoter/NN
./.
=====
In/IN
the/DT
absence/NN
of/IN
tetracyclines/NNS
,/,
the/DT
transfected/VBN
T/NN
cells/NNS
were/VBD
shown/VBN
to/TO
express/VB
the/DT
chimeric/JJ
receptor/NN
on/IN
the/DT
cell/NN
surface/NN
and/CC
could/MD
be/VB
activated/VBN
by/IN
its/PRP$
cognate/JJ
Ag/NN
,/,
leading/VBG
to/TO
the/DT
secretion/NN
of/IN
IL-2/NN
./.
=====
When/WRB
the/DT
cells/NNS
were/VBD
exposed/VBN
to/TO
increasing/VBG
concentrations/NNS
of/IN
tetracyclines/NNS
,/,
surface/NN
expression/NN
of/IN
the/DT
chimeric/JJ
receptor/NN
was/VBD
suppressed/VBN
in/IN
a/DT
dose-dependent/JJ
manner/NN
,/,
and/CC
this/DT
suppression/NN
was/VBD
sufficient/JJ
to/TO
result/VB
in/IN
complete/JJ
loss/NN
of/IN
responsiveness/NN
to/TO
the/DT
targeted/VBN
Ag/NN
./.
=====
Prolonged/JJ
suppression/NN
of/IN
trans-gene/JJ
expression/NN
for/IN
up/RB
to/TO
7/CD
days/NNS
was/VBD
observed/VBN
after/IN
doxycycline/NN
was/VBD
removed/VBN
from/IN
the/DT
cultures/NNS
,/,
but/CC
eventual/JJ
recovery/NN
of/IN
surface/NN
expression/NN
was/VBD
complete/JJ
,/,
and/CC
the/DT
absolute/JJ
time/NN
to/TO
recovery/NN
was/VBD
directly/RB
proportional/JJ
to/TO
the/DT
initial/JJ
concentration/NN
of/IN
the/DT
drug/NN
./.
=====
Pharmacologic/JJ
control/NN
of/IN
trans-gene/JJ
expression/NN
in/IN
gene-modified/JJ
T/NN
cells/NNS
will/MD
not/RB
only/RB
facilitate/VB
new/JJ
approaches/NNS
to/TO
the/DT
study/NN
of/IN
different/JJ
aspects/NNS
of/IN
T/NN
cell/NN
biology/NN
,/,
but/CC
will/MD
also/RB
provide/VB
the/DT
basis/NN
for/IN
new/JJ
gene/NN
therapy/NN
strategies/NNS
./.